ENTG — Entourage Health Share Price
0.000.00%
Last trade - 00:00- CA$1.54m
- CA$179.83m
- CA$40.71m
- 45
- 85
- 23
- 50
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.04 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -38.88% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 20.82 | 29.43 | 42.27 | 40.89 | 40.71 | n/a | n/a | 38.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.
Directors
- George Scorsis CHM
- Beth Carreon CFO
- Deborah Sikkema CHO
- Peter Blecher OTH
- Joseph Mele OTH
- G. Edmund King LED
- Jason Alexander DRC
- Andrew Bulmer DRC
- Bruce Croxon DRC (60)
- S. Randall Smallbone DRC
- Lu Cacioppo IND
- Gail Paech IND
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- July 16th, 2014
- Public Since
- November 13th, 2014
- No. of Employees
- 251
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 308,387,453
- Address
- 250 Elm St, AYLMER, N5H 2M8
- Web
- https://entouragehealthcorp.com/
- Phone
- +1 4165153923
- Auditors
- MNP LLP
Upcoming Events for ENTG
Q1 2025 Entourage Health Corp Earnings Release
Entourage Health Corp Annual Shareholders Meeting
Q2 2025 Entourage Health Corp Earnings Release
Similar to ENTG
Astron Connect
TSX Venture Exchange
CanadaBis Capital
TSX Venture Exchange
DavidsTea
TSX Venture Exchange
High Tide
TSX Venture Exchange
PharmaCorp Rx
TSX Venture Exchange
FAQ
What is the Entourage Health share price?
As of Today at 20:28 UTC, shares in Entourage Health are trading at CA$0.01. This share price information is delayed by 15 minutes.
How has the Entourage Health share price performed this year?
Shares in Entourage Health last closed at CA$0.01 and the price had moved by -66.67% over the past 365 days. In terms of relative price strength the Entourage Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -68% over the past year.
What are the analyst and broker recommendations for Entourage Health?
The overall consensus recommendation for Entourage Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Entourage Health dividend yield?
Entourage Health does not currently pay a dividend.
Does Entourage Health pay a dividend?
Entourage Health does not currently pay a dividend.
When does Entourage Health next pay dividends?
Entourage Health does not currently pay a dividend.
How do I buy Entourage Health shares?
To buy shares in Entourage Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Entourage Health?
As of the previous close price of CA$0.01, shares in Entourage Health had a market capitalisation of CA$1.54m.
Where are Entourage Health shares listed?
Here are the trading details for Entourage Health:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: ENTG
What kind of share is Entourage Health?
Based on an overall assessment of its quality, value and momentum Entourage Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Entourage Health share price forecast for 2025?
The analyst consensus target price for shares in Entourage Health is CA$0.05. That is 900% above the last closing price of CA$0.01.
Analysts covering Entourage Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Entourage Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Entourage Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -65.36%.
As of the last closing price of CA$0.01, shares in Entourage Health were trading -51.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Entourage Health PE Ratio?
The Entourage Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Entourage Health?
Entourage Health's management team is headed by:
- George Scorsis - CHM
- Beth Carreon - CFO
- Deborah Sikkema - CHO
- Peter Blecher - OTH
- Joseph Mele - OTH
- G. Edmund King - LED
- Jason Alexander - DRC
- Andrew Bulmer - DRC
- Bruce Croxon - DRC
- S. Randall Smallbone - DRC
- Lu Cacioppo - IND
- Gail Paech - IND